DB16436InvestigationalVaccines
The AdimrSC-2f (SARS-CoV-2) vaccine is developed through Adimmune Corporation, the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia . A phase I study (NCT04522089)...
- Code names
- AdimrSC-2f
What you can answer from here — as of January 16, 2021
Which companies are running trials of AdimrSC-2f, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account